279 related articles for article (PubMed ID: 33149707)
1. Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature.
Zaccherini G; Tufoni M; Bernardi M
Hepat Med; 2020; 12():153-172. PubMed ID: 33149707
[TBL] [Abstract][Full Text] [Related]
2. [The use of albumin infusion in decompensated liver cirrhosis].
Schmidt LE; Ring-Larsen H
Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
[TBL] [Abstract][Full Text] [Related]
3. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
[TBL] [Abstract][Full Text] [Related]
4. Albumin in Cirrhosis: More Than a Colloid.
Paine CH; Biggins SW; Pichler RH
Curr Treat Options Gastroenterol; 2019 Jun; 17(2):231-243. PubMed ID: 30968341
[TBL] [Abstract][Full Text] [Related]
5. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
[TBL] [Abstract][Full Text] [Related]
6. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
Hepatology; 2012 Apr; 55(4):1172-81. PubMed ID: 22095893
[TBL] [Abstract][Full Text] [Related]
7. Review article: albumin for circulatory support in patients with cirrhosis.
Ginès P; Guevara M; De Las Heras D; Arroyo V
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():24-31. PubMed ID: 12423450
[TBL] [Abstract][Full Text] [Related]
8. Long-term albumin infusion in decompensated cirrhosis: A review of current literature.
Wong YJ; Kumar R; Chua YJJ; Ang TL
World J Hepatol; 2021 Apr; 13(4):421-432. PubMed ID: 33959225
[TBL] [Abstract][Full Text] [Related]
9. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
10. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
[TBL] [Abstract][Full Text] [Related]
11. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
12. [News for usage of albumin in patients with liver disease].
Cremonese C; Uschner FE; Trebicka J
Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
[TBL] [Abstract][Full Text] [Related]
13. Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials.
Xu T; Liu W; Huang R
Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):80-88. PubMed ID: 36165067
[TBL] [Abstract][Full Text] [Related]
14. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.
Ashour AA; Atta MA; Sadek KW; Obaid KR; Ashour MA; Ashour A; Danjuma MI; Doi SA; ElZouki AN
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):479-486. PubMed ID: 32976190
[TBL] [Abstract][Full Text] [Related]
15. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
;
Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
[TBL] [Abstract][Full Text] [Related]
16. [When should we give albumin in patients with cirrhosis?].
Bochatay L; Elkrief L; Spahr L
Rev Med Suisse; 2015 Sep; 11(484):1596, 1598-601. PubMed ID: 26502620
[TBL] [Abstract][Full Text] [Related]
17. Albumin for cirrhosis-related complications.
Erstad BL
J Clin Pharm Ther; 2021 Aug; 46(4):887-894. PubMed ID: 34101215
[TBL] [Abstract][Full Text] [Related]
18. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
[TBL] [Abstract][Full Text] [Related]
19. Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
Kütting F; Schubert J; Franklin J; Bowe A; Hoffmann V; Demir M; Pelc A; Nierhoff D; Töx U; Steffen HM
J Gastroenterol Hepatol; 2017 Feb; 32(2):327-338. PubMed ID: 27149296
[TBL] [Abstract][Full Text] [Related]
20. Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict.
Arroyo V; Colmenero J
Dig Liver Dis; 2003 Sep; 35(9):668-72. PubMed ID: 14563192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
